TechSeeker Profile

Dako A/S (AKA:DakoCytomation~Dako Denmark A/S Subsidiary of Agilent Technologies Europe B.V.)
Profile last edited on: 2/10/2017

Tissue-based cancer diagnostics
TS Type
Small firm: Foreign
Status
Year Founded
1966
Last Involved Year
2009

Key People / Management

  Lars Holmkvist -- President, Agilent Diagnostics and Genomics Group

  Finn Albrechtsen -- Research & Development

  Henrik Ancher-Jensen -- Global Product Supply, Agilent Diagnostics and Genomics Group

  Anne Cathrine Baltzer -- Chairman of the Board

  Britt Meelby Jensen -- General Manager, VP

  Jacob Thaysen -- General Manager, VP, Genomics Solutions Division

Location Information

Produktionsvej 42
Glostrup, DK DK-2600
   (454) 485-9500
   www.dako.com

Public Profile

Previously doing business as DakoCytomation, Dako A/S, together with its subsidiaries, engages in the development, manufacture, and marketing of reagents, antibodies, instruments, and software for use in anatomic pathology laboratories. It offers immunohistochemistry products, including antibodies and controls, visualization systems, and ancillaries for immunohistochemistry; pharmacoDiagnostic kits that allow doctors to find the right treatment to the right patient at the right time; and molecular pathology products comprising CISH and FISH kits, FISH probes, labeled probes and detection systems, and blotting detection systems, which aid in deciphering the invisible features of cancer at a molecular level to provide diagnosis. The company also offers Special Stains kits that are able to bind to specific tissues elements; flow cytometry products comprising antibody and isotype reagents, kits and accessories, and single-color, dual-color, and triple-color reagents for the diagnosis of acute and chronic leukemia; and Specific Proteins, including reagents, kits, and accessories for turbidimetry, nephelometry, and ELISA, as well as polyclonal antibodies. In addition, it provides deployment services, instrument services, application and technical support, and service contracts. The company has collaboration agreements with Bristol-Myers Squibb for the development of pharmDx tests; and with Genentech for the regulatory submissions of HercepTest and HER2 FISH pharmDx as companion diagnostics for pertuzumab, as well as a strategic alliance with Epitomics to establish a portfolio of rabbit monoclonal antibodies. Dako A/S supplies its products in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company was founded in 1966 and is headquartered in Glostrup, Denmark. As of June 21, 2012, Dako A/S operates as a subsidiary of Agilent Technologies Europe B.V.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
Denmark
Employment
457
Revenue
$0.2B
Public/Private
Privately Held
Stock Info
---
Received SBIR $$
No

SBIR firms in the news

There are no news available.